JP2020506878A5 - - Google Patents

Info

Publication number
JP2020506878A5
JP2020506878A5 JP2019530506A JP2019530506A JP2020506878A5 JP 2020506878 A5 JP2020506878 A5 JP 2020506878A5 JP 2019530506 A JP2019530506 A JP 2019530506A JP 2019530506 A JP2019530506 A JP 2019530506A JP 2020506878 A5 JP2020506878 A5 JP 2020506878A5
Authority
JP
Japan
Prior art keywords
alkyl
ring
trek
haloalkoxy
haloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019530506A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020506878A (ja
JP7120549B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2017/044975 external-priority patent/WO2018110669A1/en
Publication of JP2020506878A publication Critical patent/JP2020506878A/ja
Publication of JP2020506878A5 publication Critical patent/JP2020506878A5/ja
Application granted granted Critical
Publication of JP7120549B2 publication Critical patent/JP7120549B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019530506A 2016-12-15 2017-12-14 Trek(twik関連kチャネル)チャネルのアクチベータ Expired - Fee Related JP7120549B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662434524P 2016-12-15 2016-12-15
US62/434,524 2016-12-15
PCT/JP2017/044975 WO2018110669A1 (en) 2016-12-15 2017-12-14 Activator of trek (twik related k+ channels) channels

Publications (3)

Publication Number Publication Date
JP2020506878A JP2020506878A (ja) 2020-03-05
JP2020506878A5 true JP2020506878A5 (enExample) 2022-03-28
JP7120549B2 JP7120549B2 (ja) 2022-08-17

Family

ID=62558996

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019530506A Expired - Fee Related JP7120549B2 (ja) 2016-12-15 2017-12-14 Trek(twik関連kチャネル)チャネルのアクチベータ

Country Status (4)

Country Link
US (2) US11046683B2 (enExample)
EP (1) EP3558992A4 (enExample)
JP (1) JP7120549B2 (enExample)
WO (1) WO2018110669A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11427600B2 (en) 2014-06-27 2022-08-30 Nogra Pharma Limited Aryl receptor modulators and methods of making and using the same
US11203582B2 (en) * 2017-06-15 2021-12-21 The Board Of Regents Of The University Of Oklahoma Benzamide derivatives for inhibiting endoplasmic reticulum (ER) stress
US20240190824A1 (en) * 2019-10-24 2024-06-13 Ono Pharmaceutical Co., Ltd. Inhibitors of trek (twik related k+ channels) channel function
CN114031601B (zh) * 2022-01-12 2022-03-18 南京桦冠生物技术有限公司 一种盐酸兰地洛尔的制备方法
WO2023164537A1 (en) * 2022-02-23 2023-08-31 Biohaven Therapeutics Ltd. Pyrazolyl compounds as kv7 channel activators
EP4482487A4 (en) * 2022-02-23 2026-04-15 Biohaven Therapeutics Ltd PYRAZOLYL COMPOUNDS USED AS KV7 CHANNEL ACTIVATORS
CN118695860A (zh) * 2022-02-23 2024-09-24 拜奥海芬治疗学有限公司 作为kv7通道激活剂的吡唑基化合物
CN114805233A (zh) * 2022-03-30 2022-07-29 华南理工大学 苯基四氮唑类xor抑制剂及其制备方法与应用

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783593A (en) * 1993-11-04 1998-07-21 Abbott Laboratories Inhibitors of squalene synthetase and protein farnesyltransferase
DE69919707T2 (de) 1998-06-19 2005-09-01 Chiron Corp., Emeryville Glycogen synthase kinase 3 inhibitoren
AU4537900A (en) * 1999-05-17 2000-12-05 Agouron Pharmaceuticals, Inc. Glucagon antagonists/inverse agonists
DE19929787A1 (de) * 1999-06-29 2001-01-04 Bayer Ag Neue 4-(2-Oxodihydrooxadiazinylphenyl)amide und ihre Verwendung
DE10060807A1 (de) * 2000-12-07 2002-06-20 Aventis Pharma Gmbh Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
EP1403255A4 (en) 2001-06-12 2005-04-06 Sumitomo Pharma RHO KINASE INHIBITORS
ATE363278T1 (de) * 2001-09-14 2007-06-15 Novo Nordisk As Neue liganden für die hisb10 zn2+ stellen des insulin-hexamers in der r-konformation
GB0124936D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
US7119120B2 (en) 2001-12-26 2006-10-10 Genzyme Corporation Phosphate transport inhibitors
PT2476667E (pt) * 2003-02-26 2014-09-18 Sugen Inc Compostos de aminoheteroarilo como inibidores da proteína quinase
EP1603917B1 (en) * 2003-03-14 2010-11-24 MediGene Ltd. Immunomodulating heterocyclic compounds
US20060160794A1 (en) * 2003-06-12 2006-07-20 Amegadzie Albert K Tachykinin receptor antagonists
EP1765379A4 (en) 2004-06-17 2009-05-27 Transform Pharmaceuticals Inc PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS AND RELEVANT USE METHOD
BRPI0516915A (pt) * 2004-12-01 2008-03-11 Devgen Nv derivados de tiazol substituìdos por 5-carboxamido que interagem com canais de ìons, particularmante com canais de ìons da famìlia kv
EP1838690A2 (en) 2004-12-21 2007-10-03 Devgen N.V. Compounds with kv4 ion channel activity
WO2007050348A2 (en) * 2005-10-21 2007-05-03 Merck & Co., Inc. Potassium channel inhibitors
DE102006005861A1 (de) 2006-02-09 2007-08-23 Aicuris Gmbh & Co. Kg Substituierte Chinolone III
WO2007098352A2 (en) * 2006-02-16 2007-08-30 Boehringer Ingelheim International Gmbh Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
US7601716B2 (en) 2006-05-01 2009-10-13 Cephalon, Inc. Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
JP2009536657A (ja) 2006-05-10 2009-10-15 レノビス, インコーポレイテッド イオンチャンネルリガンドとしてのアミド誘導体およびそれを用いる医薬組成物および方法
WO2007138110A2 (en) 2006-06-01 2007-12-06 Devgen N.V. Compounds that interact with ion channels, in particular with ion channels from the kv family
WO2007138112A2 (en) * 2006-06-01 2007-12-06 Devgen N.V. Compounds that interact with ion channels, in particular with ion channels from the kv family
ATE520651T1 (de) * 2006-10-23 2011-09-15 Pfizer Substituierte phenylmethylbicyclocarbonsäureamidverbindungen
US7956216B2 (en) 2006-12-21 2011-06-07 The Walter And Eliza Hall Institute Of Medical Research Alpha-helical mimetics
CL2008000835A1 (es) 2007-03-23 2008-10-03 Icagen Inc Pfizer Ltd Compuestos derivados de sulfonamidas, inhibidores de los canales de calcio; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor, sindrome de intestino irritable, enfermedad de crohn, taquiarritm
WO2009017838A2 (en) 2007-08-01 2009-02-05 Exelixis, Inc. Combinations of jak-2 inhibitors and other agents
EP2020413A1 (de) * 2007-08-02 2009-02-04 Bayer CropScience AG Oxaspirocyclische-spiro-substituierte Tetram- und Tetronsäure-Derivate
CA2696631A1 (en) 2007-08-17 2009-02-26 Icagen, Inc. Heterocycles as potassium channel modulators
DE102007044277A1 (de) 2007-09-17 2009-03-19 Grünenthal GmbH Substituierte Nicotinamid-Verbindungen und deren Verwendung in Arzneimitteln
JP2011503072A (ja) 2007-11-13 2011-01-27 レノビス, インコーポレイテッド イオンチャネルのリガンドとしてのアミド誘導体ならびにそれを使用する薬学的組成物および方法
WO2009117421A2 (en) * 2008-03-17 2009-09-24 Kalypsys, Inc. Heterocyclic modulators of gpr119 for treatment of disease
ES2392796T3 (es) 2008-04-17 2012-12-13 Proximagen Limited Moduladores de tipo indol del receptor nicotínico de acetilcolina alfa-7
TW201000446A (en) * 2008-05-30 2010-01-01 Astrazeneca Ab New compounds useful in pain therapy
TW201000447A (en) * 2008-05-30 2010-01-01 Astrazeneca Ab New compounds useful in pain therapy
PE20100083A1 (es) 2008-06-05 2010-02-17 Janssen Pharmaceutica Nv Combinaciones de drogas que comprenden un inhibidor de dgat y un agonista de ppar
WO2010100606A1 (en) 2009-03-03 2010-09-10 Pfizer Inc. Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
TWI461197B (zh) 2009-03-12 2014-11-21 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier
TWI475020B (zh) * 2009-03-12 2015-03-01 The substituted nicotine amide as a KCNQ2 / 3 modifier
WO2011021645A1 (ja) * 2009-08-19 2011-02-24 大日本住友製薬株式会社 2環性ウレア誘導体、またはその薬学的に許容される塩
JP2013028538A (ja) * 2009-11-13 2013-02-07 Dainippon Sumitomo Pharma Co Ltd 新規アミド誘導体
EP2630122B1 (en) * 2010-10-18 2016-11-30 RaQualia Pharma Inc Arylamide derivatives as ttx-s blockers
DE102011101446A1 (de) 2011-05-10 2012-11-15 Aicuris Gmbh & Co. Kg Herstellung von "Dense Bodies" (DB)
JP6007417B2 (ja) * 2011-05-31 2016-10-12 レセプトス エルエルシー 新規glp−1受容体安定剤および調節剤
KR101476379B1 (ko) * 2011-11-30 2014-12-29 한국과학기술연구원 페녹시프로판올 유도체 및 이를 함유하는 약학적 조성물
WO2013098416A2 (fr) 2011-12-30 2013-07-04 Ecole Nationale Superieure De Chimie De Clermont Ferrand Composes anti-douleur
CA2870572A1 (en) 2012-04-18 2013-10-24 Grunenthal Gmbh Substituted 4-aminobenzamides as kcnq2/3 modulators
AR094929A1 (es) * 2013-02-28 2015-09-09 Bristol Myers Squibb Co Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
JPWO2015012328A1 (ja) 2013-07-24 2017-03-02 武田薬品工業株式会社 複素環化合物
JP2017114765A (ja) * 2014-04-25 2017-06-29 大正製薬株式会社 トリアゾリルで置換されたヘテロアリール化合物
TN2016000542A1 (en) * 2014-06-03 2018-04-04 Idorsia Pharmaceuticals Ltd Pyrazole compounds and their use as t-type calcium channel blockers
PL3164394T3 (pl) * 2014-07-03 2020-09-07 Board Of Regents, The University Of Texas System Inhibitory GLS1 do leczenia chorób

Similar Documents

Publication Publication Date Title
TWI730986B (zh) 抗真菌化合物方法
JP2010522709A5 (enExample)
JP2015500887A5 (enExample)
JP2005536475A5 (enExample)
EA016687B8 (ru) Производные циклопропиламида
JP2015528471A5 (enExample)
JP2014502641A5 (enExample)
JP2017505790A (ja) mIDH1阻害剤としてのベンズイミダゾール−2−アミン
JP2014505688A (ja) オキサジン誘導体および神経障害の処置におけるその使用
RU2010107892A (ru) Производные феноксипирролидина, их применение и фармацевтические композиции, содержащие их
JP2018534286A5 (enExample)
JP2017511339A5 (enExample)
JP2019534310A5 (enExample)
JP2010522711A5 (enExample)
CA3148794A1 (en) 4-amino-quinolines/-quinazolines that bind to tdp-43 for the treatment of amyotrophic lateral sclerosis and related disorders
JP2015500223A5 (enExample)
JP2018505876A5 (enExample)
JP2015535247A5 (enExample)
WO2017079753A1 (en) Lysine-specific histone demethylase as a novel therapeutic target in myeloproliferative neoplasms
JP2017502063A5 (enExample)
JP2019529460A5 (enExample)
JP2016537432A5 (enExample)
CN110325523B (zh) 作为缓激肽b1受体拮抗剂的羧酸芳族酰胺
JP2017525717A5 (enExample)
JP2018501261A5 (enExample)